Page last updated: 2024-09-05
es 8891 and ro 42-5892
es 8891 has been researched along with ro 42-5892 in 2 studies
Compound Research Comparison
| Studies (es 8891) | Trials (es 8891) | Recent Studies (post-2010) (es 8891) | Studies (ro 42-5892) | Trials (ro 42-5892) | Recent Studies (post-2010) (ro 42-5892) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 69 | 19 | 8 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hiwada, K | 1 |
| Lenders, JW; Rongen, GA; Smits, P; Thien, T | 1 |
Reviews
2 review(s) available for es 8891 and ro 42-5892
| Article | Year |
|---|---|
[Renin inhibitors].
Topics: Animals; Antihypertensive Agents; Dipeptides; Humans; Hypertension; Imidazoles; Morpholines; Renin | 1992 |
Clinical pharmacokinetics and efficacy of renin inhibitors.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Biological Availability; Dipeptides; Hemodynamics; Humans; Imidazoles; Morpholines; Oligopeptides; Protease Inhibitors; Renin; Renin-Angiotensin System; Tissue Distribution | 1995 |